OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析

◆英語タイトル:OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1144FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

OraSure Technologies Inc (OSUR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

OraSure Technologies Inc (OraSure) develops, manufactures and distributes oral fluid diagnostic and collection devices and other diagnostic products for detection and diagnosis of critical medical conditions. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola virus, Zika virus and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

OraSure Technologies Inc Key Recent Developments

Mar 01,2021: OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
Nov 04,2020: OraSure Technologies announces third quarter 2020 financial results and provides update on COVID-19 developments
Oct 21,2020: OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET
Aug 05,2020: OraSure Technologies announces 2020 second quarter financial results and update on COVID-19 testing programs
May 12,2020: OraSure Technologies consolidates Microbiome services subsidiaries

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
OraSure Technologies Inc – Key Facts
OraSure Technologies Inc – Key Employees
OraSure Technologies Inc – Key Employee Biographies
OraSure Technologies Inc – Major Products and Services
OraSure Technologies Inc – History
OraSure Technologies Inc – Company Statement
OraSure Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
OraSure Technologies Inc – Business Description
Business Segment: DNAG
Overview
Performance
Business Segment: OSUR
Overview
Performance
Business Segment: Other
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Target Markets
Performance
Geographical Segment: United States
Performance
OraSure Technologies Inc – Corporate Strategy
OraSure Technologies Inc – SWOT Analysis
SWOT Analysis – Overview
OraSure Technologies Inc – Strengths
OraSure Technologies Inc – Weaknesses
OraSure Technologies Inc – Opportunities
OraSure Technologies Inc – Threats
OraSure Technologies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OraSure Technologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2021: OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
Nov 04, 2020: OraSure Technologies announces third quarter 2020 financial results and provides update on COVID-19 developments
Oct 21, 2020: OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET
Aug 05, 2020: OraSure Technologies announces 2020 second quarter financial results and update on COVID-19 testing programs
May 12, 2020: OraSure Technologies consolidates Microbiome services subsidiaries
May 06, 2020: OraSure announces 2020 first quarter financial results and provides covid-19 update
May 05, 2020: OraSure Technologies appoints Lisa Nibauer as Infectious Disease Business Unit Lead
Apr 08, 2020: OraSure Technologies appoints David J. Shulkin, M.D. to board of directors
Feb 19, 2020: OraSure announces 2019 full year and fourth quarter financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
OraSure Technologies Inc, Key Facts
OraSure Technologies Inc, Key Employees
OraSure Technologies Inc, Key Employee Biographies
OraSure Technologies Inc, Major Products and Services
OraSure Technologies Inc, History
OraSure Technologies Inc, Other Locations
OraSure Technologies Inc, Subsidiaries
OraSure Technologies Inc, Key Competitors
OraSure Technologies Inc, Ratios based on current share price
OraSure Technologies Inc, Annual Ratios
OraSure Technologies Inc, Annual Ratios (Cont...1)
OraSure Technologies Inc, Annual Ratios (Cont...2)
OraSure Technologies Inc, Interim Ratios
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OraSure Technologies Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OraSure Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hubbell Incorporated:企業の戦略・SWOT・財務情報
    Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report Summary Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ALPCO Diagnostics-医療機器分野:企業M&A・提携分析
    Summary ALPCO Diagnostics (ALPCO) is a lifescience company that imports and distributes immunoassay based products. The company’s products include immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It also provides …
  • J.M. Huber Corp:企業の戦略的SWOT分析
    J.M. Huber Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Eurofins Scientific SE:企業のM&A・事業提携・投資動向
    Eurofins Scientific SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurofins Scientific SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Takeuchi Mfg. Co Ltd:企業の戦略・SWOT・財務分析
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • QEP Resources Inc (QEP):企業の財務・戦略的SWOT分析
    QEP Resources Inc (QEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • InviCRO LLC:医療機器:M&Aディール及び事業提携情報
    Summary InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental vi …
  • Neovasc Inc (NVCN)-医療機器分野:企業M&A・提携分析
    Summary Neovasc Inc (Neovasc) is a medical device company that develops, manufactures and sells products for cardiovascular disease. The company offers products such as tiara, reducer and tissue products. Its tiara is a novel transcatheter device that is designed for treating mitral regurgitation, a …
  • sanofi-aventis US LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis US LLC (Sanofi US), a subsidiary of Sanofi is a drug company that discovers, develops and distributes various therapeutic solutions. The company provides prescription products, vaccines and other products. Sanofi US’s vaccines include ActHIB, Adacel, DAPTACEL, Decavac, Fluzone …
  • Flint Hills Resources LLC:企業の戦略的SWOT分析
    Flint Hills Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Darden Restaurants, Inc.:戦略・SWOT・企業財務分析
    Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • DeepOcean Group Holding BV:企業の戦略的SWOT分析
    DeepOcean Group Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Alecta Pensionsforsakring Omsesidigt:企業の戦略的SWOT分析
    Alecta Pensionsforsakring Omsesidigt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • USANA Health Sciences Inc (USNA):企業の財務・戦略的SWOT分析
    USANA Health Sciences Inc (USNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Space Exploration Technologies Corp:戦略・SWOT・企業財務分析
    Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • BioMedomics Inc-医療機器分野:企業M&A・提携分析
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platfo …
  • Molnlycke Health Care AB:企業の戦略的SWOT分析
    Molnlycke Health Care AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆